23.1 C
New York

Venture Capital

The Fog of War: Three Themes Crypto Investors Should Pay Attention To Now

“War is the realm of uncertainty; three quarters of the factors on which action in war is based are wrapped in a fog of...

Going Out On A Limb: Lessons I’ve Learned Chasing My Dreams

By Deanna M. Petersen, CBO of AVROBIO, as part of the From The Trenches feature of LifeSciVC One of the most common questions I get...

Recapturing Our Resilience

By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC For anyone that’s part of a fast paced,...

Israeli startup landscape maps – 2022 Q1 edition

Israeli startup landscape maps - 2022 Q1 edition - VC Cafe Total 1 Share

Heads Up And Eyes Wide Open

By Rene Russo, CEO of Xilio Therapeutics, as part of the From The Trenches features of LifeSciVC When your team’s priority is to execute a...

A Tale of Two Biotech Programs

By Aoife Brennan, CEO of Synlogic, as part of the From The Trenches feature of LifeSciVC. From the first time I heard the story of...
Category Template PlatoBlockchain Data Intelligence | Vertical Search AI

2022 predictions for AR/VR, Metaverse tech and gaming

2022 predictions for AR/VR, Metaverse tech and gaming - VC Cafe Total 1 Share

How Early Is Too Early To Establish A Commercial Function In Biotech?

By Sush Patel, CCO of Replimune as part of the From The Trenches feature of LifeSciVC. After close to 20 years at Genentech (GNE) shaping...

Hitting The Spot

By Jonathan Montagu, CEO and Co-founder of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC Today marks an important point in...

Getting Public Is Easy, Being Public Is Hard

We’ve now entered the 46th straight quarter of biotech IPO activity. New equity issuance for biotech in 2021 has broken records for the amount...

State of the Industry: 2021 Year In Review

We just held our first-ever, and hopefully only, virtual Atlas Venture Annual Meeting for our investors. Although science is winning in this pandemic, we’re clearly...

Understanding The Business Model Of Gene Therapy Companies – Peeling The Onion Back To Understand Why Time Matters

By Deanna Petersen and Holly May, Chief Business Officer and Chief Commercial Officer, respectively, of AVROBIO, as part of the From The Trenches feature...
Category Template PlatoBlockchain Data Intelligence | Vertical Search AI

Recent articles

spot_img